Sipuleucel-t, minimum of 50 million autologous cd54+ cells activated with pap-gm-csf, including leukapheresis and all other preparatory procedures, per infusion
Added on Friday, October 01, 2010
Terminated on Thursday, June 30, 2011: do not use.
Status changed on Friday, July 01, 2011 to: Discontinue procedure or modifier code- see related codes: Q2043
BETOS Classification: Chemotherapy
Medicare coverage status: Special coverage instructions apply
2012 HCPCS C9273
